Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662325B2 · kind B2 · utility
0Cited by
130References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2014 |
| Grant date | May 30, 2017 |
| Priority date | — |
| Expiry date | Dec 1, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods of attenuating, e.g., inhibiting or reducing, cellular proliferation and migration, particularly endothelial cell proliferation and migration, including that associated with angiogenesis, using opioid antagonists, including, but not limited to, those that are peripherally restricted antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.